Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jindan Fuyan granule for lymphatic cyst after lymphadenectomy in endometrial or cervical cancer
ChiCTR2100050155Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in lymphocele, endometrial cancer (EC) and Cervical Cancer (CC) comparing Jindan Fuyan granule with Control: observation only (2 arms). Primary endpoint: Change of lymphatic cyst size. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
Jindan Fuyan
03
Conditions
lymphoceleendometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2100050155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050155.